Best Place to Inject Cypionate: Site Pain Protocol
At a glance
- Labeled route / Deep intramuscular injection into the gluteal muscle, never intravenous [1]
- Labeled reaction / Injection-site pain and inflammation, listed without a rate [1]
- Site comparison / Ventrogluteal beat dorsogluteal for pain in a 29-study review [2]
- Warming the injectate / Did not reduce injection pain in that review [2]
- Allergy / Hypersensitivity, including skin manifestations and anaphylactoid reactions, is listed [1]
- Infection signs / Spreading redness, warmth, drainage, fever with chills [3]
- Subcutaneous data / Small studies in transgender men on weekly doses, not the labeled IM regimen [4][5]
Where does the label say to inject?
Depo-Testosterone is for intramuscular use only, should not be given intravenously, and intramuscular injections should be given deep in the gluteal muscle [1]. The labeled replacement dose for hypogonadal men is 50 to 400 mg every two to four weeks [1]. The product comes in 100 mg/mL and 200 mg/mL strengths, so the same milligram dose is twice the volume when the lower strength is used [1].
The label describes the target in terms of muscle and depth rather than naming a specific quadrant of the gluteal region [1].
Which gluteal site hurts less?
A 2021 systematic review and meta-analysis in PLoS One of intramuscular injection technique in adults included 29 studies, 20 of which went into the meta-analysis, and identified 13 techniques [2]. Injections into the ventrogluteal site reduced pain compared with the dorsogluteal site, based on 2 studies with a standardized mean difference of -0.43 (95% CI -0.81 to -0.06) [2].
The review found reductions with several other techniques: manual pressure applied to the site (4 studies, SMD -0.85), rhythmic tapping described as the Helfer technique (3 studies, SMD -2.95), and acupressure-style sustained then intermittent pressure (4 studies, SMD -1.62) [2]. A plastic pressure device called ShotBlocker did not significantly reduce pain (2 studies, SMD -0.51, 95% CI -1.58 to 0.56), evidence on the Z-track technique was insufficient (2 studies, SMD -0.20, 95% CI -0.41 to 0.01), and results for changing the needle after drawing up the dose were conflicting [2].
The authors reported very high unexplained heterogeneity between studies, poor reporting of randomization, and possible bias from unblinded assessors or participants [2]. Read the site comparison as general intramuscular evidence, not as a finding specific to testosterone cypionate.
Does warming the injectate help?
Warming the injectate did not reduce pain in the review's results [2].
Can testosterone cypionate be given subcutaneously?
The clearest data on injecting testosterone under the skin come from three small studies in transgender patients on weekly dosing [4][5][6].
In a crossover pilot of 14 transgender men, total testosterone exposure was comparable between subcutaneous and intramuscular injection (mean dose-normalized AUC 1.7 plus or minus 0.6 vs 1.9 plus or minus 0.6 nmol·days/L/mg), and self-reported pre-injection anxiety, pain during injection and post-injection pain were all lower during the subcutaneous phase, with wide variation between and within patients [4]. In a cohort of 63 female-to-male transgender patients on weekly subcutaneous cypionate or enanthate, minor and transient local reactions occurred in 9 of the 63; of the 22 who switched from intramuscular injection, all preferred the subcutaneous route, 20 markedly and 2 mildly [5]. In 11 transgender patients already receiving weekly subcutaneous cypionate, total and free testosterone stayed stable across the week between injections [6].
The labeled route for Depo-Testosterone remains deep gluteal intramuscular injection [1], so the weekly subcutaneous schedules in these studies describe a different regimen from the one on that label.
When is site pain something more serious?
The Depo-Testosterone label lists hypersensitivity, including skin manifestations and anaphylactoid reactions, among its adverse reactions [1].
Cellulitis is a common skin infection caused by bacteria that affects the middle layer of the skin and the tissues below. MedlinePlus describes redness or inflammation that gets bigger as the infection spreads, warmth, tenderness, swelling, fever with chills and sweating, fatigue, and possible drainage when pus collects [3]. It lists persistent fever, drowsiness, lethargy, blistering over the red area and red streaks that spread as new symptoms during cellulitis treatment, and notes that a provider may mark the edge of the redness with a pen to see whether it crosses the line in the following days [3].
A 2024 case report in the journal Contact Dermatitis described a delayed hypersensitivity reaction to testosterone cypionate injections [7]. One case report does not show how often that happens.
What is in the vial?
The label's formulation is testosterone cypionate in cottonseed oil with benzyl benzoate and benzyl alcohol as the preservative [1].
HealthRX.com offers testosterone cypionate by prescription.
Frequently asked questions
Where is the best place to inject testosterone cypionate?
How long does testosterone cypionate injection-site pain last?
Does warming the injectate reduce injection pain?
Can testosterone cypionate be injected subcutaneously instead?
Is the carrier oil causing the pain?
What does cellulitis look like?
References
- U.S. National Library of Medicine, DailyMed. Depo-Testosterone (cypionate) intramuscular, Pharmacia & Upjohn/Pfizer (testosterone cypionate) prescribing information. Depo-Testosterone (cypionate) intramuscular, Pharmacia & Upjohn/Pfizer (testosterone cypionate) label
- Ayinde O, Hayward RS, Ross JDC. The effect of intramuscular injection technique on injection associated pain; a systematic review and meta-analysis. PLoS One. 2021;16(5):e0250883. The effect of intramuscular injection technique on injection associated pain; a systematic review and meta-analysis
- Cellulitis: MedlinePlus Medical Encyclopedia. Cellulitis: MedlinePlus Medical Encyclopedia
- Wilson DM, Kiang TKL, Ensom MHH. Pharmacokinetics, safety, and patient acceptability of subcutaneous versus intramuscular testosterone injection for gender-affirming therapy: A pilot study. Am J Health Syst Pharm. 2018;75(6):351-358. Pharmacokinetics, safety, and patient acceptability of subcutaneous versus intramuscular testosterone injection for gender-affirming therapy: A pilot study
- Spratt DI, Stewart II, Savage C, Craig W, Spack NP, Chandler DW, et al. Subcutaneous Injection of Testosterone Is an Effective and Preferred Alternative to Intramuscular Injection: Demonstration in Female-to-Male Transgender Patients. J Clin Endocrinol Metab. 2017;102(7):2349-2355. Subcutaneous Injection of Testosterone Is an Effective and Preferred Alternative to Intramuscular Injection: Demonstration in Female-to-Male Transgender Patients
- McFarland J, Craig W, Clarke NJ, Spratt DI. Serum Testosterone Concentrations Remain Stable Between Injections in Patients Receiving Subcutaneous Testosterone. J Endocr Soc. 2017;1(8):1095-1103. Serum Testosterone Concentrations Remain Stable Between Injections in Patients Receiving Subcutaneous Testosterone
- Ponce MB, Schauberger E, Connor E, Reeder M. Delayed hypersensitivity reaction to testosterone cypionate injections. Contact Dermatitis. 2024;91(4):364-365. Delayed hypersensitivity reaction to testosterone cypionate injections